Monthly Archives: November 2017

PD-1 and PD-L1 targeting sgRNA Lentiviral Particles

GeneCopoeia offers premade lentiviral particles carrying sgRNA targeting PD-1 or PD-L1 for CRIPSR-Cas9 genome editing in primary cells or cell lines. Ready-to-use purified lentiviral particles can be used in combination with Cas9 nuclease clones, Cas9 lentiviral particles, Cas9 stable cancer cell lines or premade labeled cancer cell lines for effective human PD-1, PD-L1 gene knockout in a variety of cell types including difficult-to-transfect cells, primary cells, stem cells and non-dividing cells as well as in vivo use for transgenic animals.    Advantages  ......
Posted in Applications, Purified lentiviral particles, Ultra-purified lentiviral particles